-
Mashup Score: 12023 Herpes Research Update from Dr. Keith Jerome - 7 month(s) ago
In recognition of National Herpes Awareness Day, Fred Hutch virologist Dr. Keith Jerome shares a special message about the research he and others are conduct…
Source: www.youtube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0The value of herpes zoster prevention in patients aging with HIV: A narrative review - 7 month(s) ago
Objective Review the evidence on the incidence and impact of herpes zoster among people living with HIV and the potential impact of recombinant zoster vaccine for people aging with HIV. Methods Na…
Source: onlinelibrary.wiley.comCategories: Infectious Disease, Latest HeadlinesTweet-
📖 Scientists with Dr. Nicolas Dauby at @ChuSaintPierre #review the evidence on the incidence and impact of #herpes zoster among people living with# HIV and the potential impact of recombinant zoster 💉 #vaccine for people #aging with HIV. @HIV_Medicine | https://t.co/35IfGk2X7f https://t.co/hlxJMwmtru
-
-
Mashup Score: 12
Federal health officials get an earful from herpes patients and researchers on the enormous toll and the host of unmet needs.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet-
People living with #herpes often struggle to get an accurate diagnosis, have few care options, and get little useful guidance from health care providers. There's a movement afoot to try to change that, @jasonmmast reports. https://t.co/0UzSy9Id6Q
-
-
Mashup Score: 0
The US Preventive Services Task Force (USPSTF) reaffirmed previous recommendations against routine serologic screening for genital herpes infection among asymptomatic adolescents and adults, including pregnant individuals.
Source: AJMCCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 1Week in review: Preschool mobile vision screening, vision impairment in older adults, kidney function and AMD - 1 year(s) ago
Mobile vision screening identifies vision correction needs in preschoolers, vision impairment is common in older adults, having AMD increases the risk of renal disease, and many recipient corneas are
Categories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 4
BioNtech has dosed the first patient with its BNT163 herpes vaccine candidate designed to prevent genital lesions as part of a first-in-human Phase 1 clinical research study, the German vaccine maker said on Wednesday.
Source: ReutersCategories: Expert Picks, Latest HeadlinesTweet
-
Mashup Score: 10The science events to watch for in 2023 - 1 year(s) ago
Moon landings, mRNA vaccines and climate finance are among the developments set to shape research in the coming year.
Source: www.nature.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Shingles associated with long-term risk for major CV events - 1 year(s) ago
Compared with those without it, adults with herpes zoster, also known as shingles, had higher long-term risk for a major CV event, researchers reported.“These findings suggest there are long-term cardiovascular implications of herpes zoster,” Sharon G. Curhan, MD, ScM, assistant professor of medicine at Brigham and Women’s Hospital and Harvard Medical School, and colleagues
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Researching herpes treatments with 'skin-on-chip' technology - 2 year(s) ago
With a new device she calls a “skin-on-chip” platform, Fred Hutch researcher Dr. Jia Zhu and her team have built and tested a prototype tool that could help researchers speed the development of herpes treatments. The device is seeded with human skin cells and kept alive with a network of living blood vessels. It can be infected with herpes and treated with experimental drugs.
Source: Fred HutchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Researching herpes treatments with 'skin-on-chip' technology - 2 year(s) ago
With a new device she calls a “skin-on-chip” platform, Fred Hutch researcher Dr. Jia Zhu and her team have built and tested a prototype tool that could help researchers speed the development of herpes treatments. The device is seeded with human skin cells and kept alive with a network of living blood vessels. It can be infected with herpes and treated with experimental drugs.
Source: Fred HutchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
In recognition of #NationalHerpesAwareness Day, Fred Hutch virologist Dr. Keith Jerome shares an update on efforts to develop a cure for #herpes infections. Watch here: https://t.co/6BjNHpnLkO